Enhancing lesion detection in liver and kidney CT scans via lesion mask selection from two models: A main model and a

Abdullah F Al-Battal1, Van Ha Tang2, Quang Duc Tran2

  • 1Electrical and Computer Engineering Department, UC San Diego, La Jolla, CA, USA; Electrical Engineering Department, King Fahd University of Petroleum and Minerals, Saudi Arabia.

PubMed

Insights

This study introduces a novel ensemble method to improve automated tumor detection and segmentation in CT scans, significantly reducing false negatives for liver and kidney cancers. The approach enhances diagnostic accuracy by selecting the best segmentation mask based on feature separation.

Area of Science:

  • Medical Imaging
  • Artificial Intelligence
  • Oncology

Background:

  • Automated tumor segmentation in CT scans aids cancer diagnosis and treatment planning.
  • Current deep learning models struggle with detecting small, heterogeneous, or low-contrast lesions, leading to high false negative rates.

Purpose of the Study:

  • To enhance the accuracy of automated tumor detection and segmentation in liver and kidney CT scans.
  • To address the limitations of existing models in identifying challenging lesions.

Main Methods:

  • A selective ensemble approach using two UNet-based models with ConvNext blocks was developed.
  • One model segments all lesions; the second is fine-tuned for small lesions.
  • A feature-based selection mechanism identifies the optimal segmentation mask by maximizing intensity separation between lesions and surrounding tissue.

Main Results:

  • The proposed method demonstrated improved detection and segmentation performance across three datasets.
  • It successfully increased the number of detected lesions compared to state-of-the-art models.
  • The approach showed particular efficacy in identifying challenging small or heterogeneous tumors.

Conclusions:

  • The selective ensemble approach offers a significant advancement in automated tumor analysis for liver and kidney CT scans.
  • This method has the potential to improve clinical decision-making by providing more accurate and comprehensive tumor detection.
  • Further validation on diverse datasets could solidify its role in clinical practice.

Related Concept Videos